Progress of visual dysfunction in Parkinson's disease

Acta Neurologica Scandinavica

Volumn 105, Issue 4, 2002, Pages 256-260

  Muller T ^a   Woitalla, D ^a   Peters, S ^a   Kohla, K ^a   Przuntek, H ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Color discrimination; Color vision; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLOR VISION; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; PARKINSON DISEASE; SCORING SYSTEM; VISION TEST; VISUAL DISORDER;

COLOR PERCEPTION; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0036105213     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.1o154.x     Document Type: Article

References (21)

1. Nigral and extranigral pathology in Parkinson's disease
2. The visual system in Parkinson's disease
3. Vision in Parkinson's disease: What are the deficits and what are their origins?
4. Decreased dopamine in the retinas of patients with Parkinson's disease
5. Proposals for scoring and assessing the 100-Hue test
6. Decreased color discrimination and contrast sensitivity in Parkinson's disease
7. Distorted color discrimination in 'de novo' parkinsonian patients
8. Colour vision abnormalities and movement time in Parkinson's disease
9. Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease
10. Distorted colour discrimination in Parkinson's disease is related to severity of the disease
11. L-Dopa improves colour vision in Parkinson's disease
12. Effects of apomorphine on visual functions in Parkinson's disease
13. Core assessment program for intracerebral transplantations (CAPIT)
14. Levodopa improves spatial contrast sensitivity in Parkinson's disease
15. New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease
16. Colour discrimination thresholds in Parkinson's disease: Results obtained with a rapid computer-controlled colour vision test
17. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels
18. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients
19. Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease
20. Choice reaction time after levodopa challenge in parkinsonian patients
21. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: A transcranial magnetic stimulation study